Summit Therapeutics Inc. Earnings Per Share (Basic)
Summit Therapeutics Inc. (SMMT) reported Earnings Per Share (Basic) of -$0.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-23
- Summit Therapeutics Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.28.
- Summit Therapeutics Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.24.
- Summit Therapeutics Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.29.
- Summit Therapeutics Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.31.
- Summit Therapeutics Inc. earnings per share, basic for fiscal 2025 was -$1.44.
- Summit Therapeutics Inc. earnings per share, basic for fiscal 2024 was -$0.31.
- Summit Therapeutics Inc. earnings per share, basic for fiscal 2023 was -$0.99.
- Summit Therapeutics Inc. earnings per share, basic for fiscal 2022 was -$0.41.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 11 month | Earnings Per Share, Basic 11 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.28 10-Q · filed 2026-07-23 | -$0.52 10-Q · filed 2026-07-23 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-07-23 | ||||||
| 2026-03-31 | -$0.24 10-Q · filed 2026-04-30 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$1.59 derived: net income ÷ weighted average shares · filed 2026-07-23 | ||||||
| 2025-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$1.44 10-K · filed 2026-02-23 | ||||||
| 2025-09-30 | -$0.31 10-Q · filed 2025-10-20 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$1.16 10-Q · filed 2025-10-20 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-07-23 | ||||||
| 2025-06-30 | -$0.76 10-Q · filed 2026-07-23 | -$0.85 10-Q · filed 2026-07-23 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$1.01 derived: net income ÷ weighted average shares · filed 2026-07-23 | ||||||
| 2025-03-31 | -$0.09 10-Q · filed 2026-04-30 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-07-23 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-07-23 | ||||||
| 2024-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.31 10-K · filed 2026-02-23 | ||||||
| 2024-09-30 | -$0.08 10-Q · filed 2025-10-20 | -$0.16 derived: net income ÷ weighted average shares · filed 2025-10-20 | -$0.22 10-Q · filed 2025-10-20 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2024-06-30 | -$0.09 10-Q · filed 2025-08-11 | -$0.15 10-Q · filed 2025-08-11 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2024-03-31 | -$0.06 10-Q · filed 2025-05-01 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2023-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.99 10-K · filed 2026-02-23 | ||||||
| 2023-09-30 | -$0.03 10-Q · filed 2024-10-30 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-10-30 | -$0.98 10-Q · filed 2024-10-30 | -$1.16 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2023-06-30 | -$0.02 10-Q · filed 2024-08-06 | -$1.03 10-Q · filed 2024-08-06 | -$1.27 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2023-03-31 | -$1.43 10-Q · filed 2024-05-01 | -$1.69 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$2.00 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$2.36 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||||
| 2022-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.41 10-K · filed 2025-02-24 | ||||||
| 2022-09-30 | -$0.10 10-Q · filed 2023-11-07 | -$0.14 10-Q · filed 2022-11-09 | -$0.22 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.37 10-Q · filed 2023-11-07 | -$0.52 10-Q · filed 2022-11-09 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||
| 2022-06-30 | -$0.12 10-Q · filed 2023-08-09 | -$0.17 10-Q · filed 2022-08-11 | -$0.27 10-Q · filed 2023-08-09 | -$0.38 10-Q · filed 2022-08-11 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-17 | ||||
| 2022-03-31 | -$0.15 10-Q · filed 2023-05-11 | -$0.22 10-Q · filed 2022-05-11 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-04-17 | |||||
| 2021-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-04-17 | -$0.67 10-K · filed 2023-03-09 | -$0.96 10-K · filed 2022-03-17 | |||||
| 2021-09-30 | -$0.20 10-Q · filed 2022-11-09 | -$0.46 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.67 10-Q · filed 2022-11-09 | -$0.68 10-Q · filed 2021-11-15 | -$0.86 derived: net income ÷ weighted average shares · filed 2022-12-21 | |||||
| 2021-06-30 | -$0.27 10-Q · filed 2022-08-11 | -$0.48 10-Q · filed 2022-08-11 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.92 derived: net income ÷ weighted average shares · filed 2022-12-21 | ||||||
| 2021-03-31 | -$0.21 10-Q · filed 2022-05-11 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.65 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-12-21 | ||||||
| 2020-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.44 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-12-21 | -$0.76 10-K/A · filed 2022-12-21 | ||||||
| 2020-09-30 | -$0.26 10-Q · filed 2021-11-15 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$0.58 10-Q · filed 2021-11-15 | |||||||
| 2020-06-30 | -$0.23 10-Q · filed 2021-08-12 | -$0.32 10-Q · filed 2021-08-12 | ||||||||
| 2020-03-31 | -$0.09 10-Q · filed 2021-05-17 | |||||||||
| 2019-12-31 | -$0.89 10-K · filed 2021-03-31 | -$0.88 8-K · filed 2020-09-29 | ||||||||
| 2019-09-30 | -$0.20 10-Q · filed 2020-11-16 | -$0.41 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.63 10-Q · filed 2020-11-16 | |||||||
| 2019-06-30 | -$0.21 8-K · filed 2020-09-29 | -$0.44 8-K · filed 2020-09-29 | ||||||||
| 2019-01-31 | $0.63 10-K · filed 2021-03-31 | $0.58 8-K · filed 2020-09-29 | ||||||||
| 2018-01-31 | -$2.01 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |